[HTML][HTML] Cardiac-resynchronization therapy for mild-to-moderate heart failure
Background Cardiac-resynchronization therapy (CRT) benefits patients with left ventricular
systolic dysfunction and a wide QRS complex. Most of these patients are candidates for an …
systolic dysfunction and a wide QRS complex. Most of these patients are candidates for an …
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and …
Background— Oral anticoagulation (OAC) therapy is effective in atrial fibrillation but requires
vigilance to maintain the international normalized ratio in the therapeutic range. This report …
vigilance to maintain the international normalized ratio in the therapeutic range. This report …
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial
…, J Champagne, LD Sterns, H Beresh, JS Healey… - Jama, 2014 - jamanetwork.com
Importance Atrial fibrillation (AF) is the most common rhythm disorder seen in clinical practice.
Antiarrhythmic drugs are effective for reduction of recurrence in patients with symptomatic …
Antiarrhythmic drugs are effective for reduction of recurrence in patients with symptomatic …
Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …
Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
Background— Cardiac arrest without evident cardiac disease may be caused by subclinical
genetic conditions. Provocative testing to unmask a phenotype is often necessary to detect …
genetic conditions. Provocative testing to unmask a phenotype is often necessary to detect …
A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome
…, JH Svendsen, WD Toff, JS Healey… - European heart …, 2011 - academic.oup.com
Aims In patients with sick sinus syndrome, bradycardia can be treated with a single-lead
pacemaker or a dual-chamber pacemaker. Previous trials have revealed that pacing modes …
pacemaker or a dual-chamber pacemaker. Previous trials have revealed that pacing modes …
[HTML][HTML] Subclinical atrial fibrillation and the risk of stroke
JS Healey, SJ Connolly, MR Gold… - New England journal …, 2012 - Mass Medical Soc
Background One quarter of strokes are of unknown cause, and subclinical atrial fibrillation
may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial …
may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial …
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data
Background— Several randomized trials have compared atrial-based (dual-chamber or atrial)
pacing with ventricular pacing in patients with bradycardia. No trial has shown a mortality …
pacing with ventricular pacing in patients with bradycardia. No trial has shown a mortality …
Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial
…, GH Mairesse, P Mabo, AJ Camm, JS Healey - American heart …, 2017 - Elsevier
Background Device-detected subclinical atrial fibrillation (AF) refers to infrequent, short-lasting,
asymptomatic AF that is detected only with long-term continuous monitoring. Subclinical …
asymptomatic AF that is detected only with long-term continuous monitoring. Subclinical …
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of …
Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke
prevention in atrial fibrillation. The purpose of this study was to compare their risks of …
prevention in atrial fibrillation. The purpose of this study was to compare their risks of …